APA (7th ed.) Citation

Lim, Y., Chan, H. L., Ahn, S. H., Seto, W. K., Ning, Q., Agarwal, K., . . . Buti, M. (2023). Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B. JHEP reports, 5(10), 100847. https://doi.org/10.1016/j.jhepr.2023.100847

Chicago Style (17th ed.) Citation

Lim, Young-Suk, et al. "Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate Reduce Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B." JHEP Reports 5, no. 10 (2023): 100847. https://doi.org/10.1016/j.jhepr.2023.100847.

MLA (9th ed.) Citation

Lim, Young-Suk, et al. "Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate Reduce Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B." JHEP Reports, vol. 5, no. 10, 2023, p. 100847, https://doi.org/10.1016/j.jhepr.2023.100847.